Member Info for MrTriumph

Bit,
Good find, so, Mankayan renewal now a shoe in!!
Bring it on, once that news lands hello 30's
Mr T

IK
Dont think Steve is anything to do with Kwack, is Kwack that clever??? From what I know that is a big fat NO!!!!
Kwack is unwell I think, notice how he pops up once a week talks to himself with the same content then disappears!!
Must be a relaxation of his terms and conditions, once a week, he gets an hour to himself without any carers lol
Come on bzt let's have a good end to 2021 and a cracking start to 2022.
Mr T

Dvh
Absolutely 100% correct.

Just look at UFO valuation, still no income there either, yet their valuation is 5 times ours!!! with virtually the same shares in issue?

Mr t

Up 17% on the alternative platform? News Leak anyone?

Mr T

Hello hello hello, whats all this then, lots of trades today after days of inaction!!!

All aboard for the 2022 bull run on bzt is what I say, I cant see this down here for too much longer.

Mr T

Bzt.pl.gb
The other platform Prickly one went through as a sell this pm !!!!!
Thanks for the notes, will read through later.
Mr T

IK,
bzt for me is still the number one stock, so many projects with so much potential, as I keep saying show me one with such a low m/c with so much to lok forward to. Also now with CB focusing his energy more and more next year here, and I know he is buzzing about the JV with Caerus and what the future may hold for that project.
Mankayan still remains my main focus at the minute with the 25yr licence approval soon to be announced followed by the IPO on the ASX, that will surely see the sp back into the 30's at least.
I'm also sticking with N4Pharma despite it being a disaster since I invested, but as I know pharma stocks are a long play, trick is though to be in at the lows for large gains.
Got a couple of other small investments at the minute but they are on the back burner for now.
Mr T

Se attached for current operations in the Phillipines and the current situation regarding the licence renewal. We are No 30 on the list?
Looks like all applications are eventually renewed but there are one or two explorationlicences still outstanding, but again any application made earlier all approved. That was before the recent changes in the Governments stance regarding mining in the Phillipines, now thet are more in favour than previously.
Be a very nice Xmas present to get this sorted this month??
https://mgb.gov.ph/attachments/article/50/OCT_2021_MPSA_2A.pdf
Mr T

Bahrain,
Agreed need him to fully focus on bzt for at least a couple of years, in which time, we should have Mankayan listed with a valuation and in a position to cash in some of that value, Cyrus may well be an up and running mine with income coming in, Hope should be in a better postion than it is now for sure with a JV a possiblity, Kalengwa, again the test will be to prove up the asset, again, should be in a much better position that it is currently, then there are other interests still in cold storage if you like, but as everyone with a good knowledge of bzt knows, we only need one of these to take off to see our m/c rocket.
Mankayan will certainly be the catalyst to a significant rise in the sp here once the 25yr extension is agreed and IDM have listed on ASX, then we will know the value of our 27.5%!!!
So if Mankayan is all done and listed, lets say by June 2022, the sp will certainly be 4/5 times the current level, thats me being pessimistic!!! as it could be higher. Remember 1p equals m/c of roughly £49M which is nothing realy for a growing copper and gold outfit with significant assets on its books. Its all about proving these assets up though as anyone with any knowledge in this field will tell you.
Here's to a much better 2022, as for Covid, well I'm not concerned about that, the only negative for me, is that, the licence extension application for Mankayan is obviously being slowed up in its process, but will get there in the end.

Mr T

andmillsy,

Didnt he infer to shareholders at a recent meeting that he considered us, bzt, to be the place where he would put his money right now, when he was pushed on this particular matter? cant remember who posted this, but I think it was!

Mr T

Well said Prickly, alas I'm afraid that it will fall on deaf ears!!!

Ignore from now on is the best action.

Mr T

IK,
I take it from your posts that you are now a holder of bzst stock? is that correct.

I thought you had sold out?

Which is it?

Mr T

Excellent update now posted here today, this looks very promising indeed.
Mr T

Good point Bahrain, especially after our last fiasco with XRF results and then assays inferring these were in fact incorrect, although I assume this is still being investigated by the company.

Mr T

Morning,
Yes an excellent update over at Caerus, but, no RNS on here!!

As we are now a major contributor to these project I would have expected an RNS on this matter here today? Anyone got any reasons as to why bzt are not issuing these updates?

Mr T

BCB,
I'm not sure of timelines, all I will say however is that IDM Mankayan is all ready and set up to go as far as I'm aware, they are waiting the licence renewal, which I believe if it wasn't for the Covid bull**** would have been extended and agreed by now, then there will be an IPO on the ASX market.
Mr T

BCB,
Don't forget the listing on ASX once the licence is renewed, then we will have a value on one assets which under the current circumstances, will be more than the current MC!!!

Mr T

Well, good news and bad news, the market however focused on the bad news, as they always do!!

A 25% drop for what?? this was always a cancer focused company, and in spite of the bull**** Covid being mentioned there was never any real increase in the sp prior to any updates.
So now the covid bull**** is out of the way the sp tanks!! in spite of the upbeat statement relating to our primary objective!!

The mm's have had a field day here taking shares of people for silly amount's! but that is the way of the AIM market I'm afraid, everyone looking for a quick buck!

The important bits from todays RNS: ignore the sideshow.

Next Steps

Taking into account the recent data and very positive oncology work, the Company has strategically decided to focus its resources on advancing its work in gene therapy whilst continuing its vaccine delivery efforts in conjunction with partners working with specific, proprietary products. Once the full analysis is complete on the oncology study, the Company will scope out the next study in this area to commence early in the new year with a view to demonstrating a clinically relevant therapeutic effect with a targeted end point that will enable the Company to enter commercial discussions in this area.

Nigel Theobald, Chief Executive Officer of the Company, commented: "We are delighted with the results from our more expansive oncology study repeating and validating the earlier results from our pilot. Having successfully formulated a monodispersed version of Nuvec®, this has allowed the Company to determine the most attractive way for it to commercialise Nuvec®.

"Whilst the results on the vaccine work from Evotec were unexpected, the proof-of-concept data, that we have collated to date, has been sufficient to allow the Company to sign MTAs with potential vaccine collaborators. We expect other collaborations will follow, so it makes sense to continue the vaccine platform optimisation with collaborators who own their own DNA plasmids and mRNA compounds. This will allow us to focus internal efforts on developing commercial products in the gene therapy space.

"The Company remains well funded to complete the next phase of its gene therapy product development which we believe will give it the greatest chance to negotiate partnerships in this space with a range of different companies.

"I believe this evolved strategy gives us the best opportunity to grow the Company into a successful and sustainable life sciences business.

So, next important news in 2022, question, where will the sp be by then, could be lower than now, hopefully not but as there is little in the way of patience in the market, d9ont expect this to be lower.

So a view as to whether hold, top up or sell !!! could be anyone of these in this case. The good news is further cemented with the statement "Fully Funded" so no worries there for the immediate future.

Hold for now.

Mr T

BCB
I really think that any positive news on the Mankayan licence and this will double.

The licensing authorities in the Philippines are behind due to Covid restrictions and the working from home *******s! therefore the licence renewal will take longer than expected.

Plenty of news still to come here so this remains my number one for a large increase, may add over the coming days whilst the sp is too low!!

Good luck

Mr T

God I Hope not, I was in Bids around 8/9 and all it did was drop. So after news last week its still only half of the price when I got in!!!! Sold at a loss around 7ish!!!
So if N4P followed that it woukd drop to 2 and then rise to 4 on massive news!!!!
Looking for some updates here now, been far too long , I still think if we have several positive updates then we could see 30p plus here.

Mr T